Voxeleron at ARVO 2018
With ARVO upon us, we’d like to take the opportunity to reach out, reconnect, and pass on some news and updates. We hope that these are of interest and, better still, that we can meet up at ARVO. You can…
With ARVO upon us, we’d like to take the opportunity to reach out, reconnect, and pass on some news and updates. We hope that these are of interest and, better still, that we can meet up at ARVO. You can…
We are delighted to announce that our abstract, Deep Learning for Prediction of AMD Progression was accepted for presentation at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). The research was performed in collaboration with Professor…
Voxeleron is excited to announce their collaborative role in the Sys4MS (Systems for Multiple Sclerosis) multi-center research initiative aimed at developing new tools for personalized management of patients with MS and other complex diseases. Sys4MS focuses on five specific areas:…
Voxeleron announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $222,991 from the National Institutes of Health’s (NIH) National Center for the Advancement of Translational Sciences (NCATS), to further develop device-independent retinal…
We are pleased to report that our abstract, "Deep convolutional neural networks for automated OCT pathology recognition" was accepted for presentation at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). The research was performed…